Aldeyra The

ALDX

$1.48

-0.67%

2026-09-03 16:00:01 EDT-$0.01

Healthcare

Biotechnology

NASDAQ

Active Trading

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Todd C. Brady	Chief Executive Officer, President & Director	USD 903,000	—	1972	Active
Michael Alfieri	Head of Finance and Principal Financial & Accounting Officer	USD 243,994		1965	Active
Laura Nichols	Operations Manager	—	—	—	Active
Adam Lazorchak	Director of Translational Sciences & Non-Clinical Development	—	—	—	Active
David Burke	Head of Investor Relations	—	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-04-27	2025	Todd C. Brady, M.D., Ph.D.	President President and Chief Chief Executive Officer	Founder / CEO	$700.00K	$0	$0	$3.80M	$189.00K	$14.00K	$4.70M
2026-04-27	2025	Stephen G. Machatha, Ph.D.	Chief Chief Development Officer	C-Level	$400.00K	$0	$0	$950.34K	$0	$101.80K	$1.45M
2026-04-27	2025	Michael Alfieri	Principal Principal Financial Officer and Principal Principal Accounting Officer	Other	$0	$0	$0	$0	$0	$243.99K	$245.96K
2026-04-27	2024	Todd C. Brady, M.D., Ph.D.	President President and Chief Chief Executive Officer	Founder / CEO	$591.63K	$0	$0	$3.00M	$325.40K	$13.80K	$3.93M
2026-04-27	2024	Stephen G. Machatha, Ph.D.	Chief Chief Development Officer	C-Level	$392.34K	$0	$0	$1.13M	$156.94K	$13.80K	$1.69M
2026-04-27	2024	Michael Alfieri	Principal Principal Financial Officer and Principal Principal Accounting Officer	Other	$0	$0	$0	$0	$0	$111.65K	$111.65K

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of ALDX

RELATIONS

Upstream

AbbVie Inc.NYSE:ABBV Janssen Research & Development (Johnson & Johnson)NYSE:JNJUnnamed Contract Manufacturing Organizations (CMOs/CDMOs)Unnamed API / Excipient Raw Material SuppliersUnnamed Clinical Research Organizations (CROs)

Downstream

AbbVie Inc.NYSE:ABBV Janssen Research & Development (Johnson & Johnson)NYSE:JNJPharmaceutical Wholesalers (Undefined — Pre-Commercial)

Proxies

Tarsus Pharmaceuticals, Inc.NASDAQ:TARS Kala Pharmaceuticals, Inc.NASDAQ:KALA Ocular Therapeutix, Inc.NASDAQ:OCUL

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer